Familial Idiopathic Pulmonary Fibrosis

New England Journal of Medicine

Volumn 314, Issue 21, 1986, Pages 1343-1347

  Bitterman, Peter B ^a   Rennard, Stephen I ^a   Keogh, Brendan A ^a   Wewers, Mark D ^a   Adelberg, Steven ^a   Crystal, Ronald G ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RADIOISOTOPE;

AUTOSOMAL DOMINANT INHERITANCE; CYTOLOGY; DIAGNOSIS; FIBROSING ALVEOLITIS; HEREDITY; HISTOLOGY; HUMAN; HUMAN EXPERIMENT; INHERITANCE; LUNG FIBROBLAST; LUNG FIBROSIS; LUNG LAVAGE; LUNG SCINTISCANNING; PNEUMONIA; PRIORITY JOURNAL; RESPIRATORY SYSTEM;

ADULT; AGED; BIOPSY; FEMALE; GALLIUM RADIOISOTOPES; GENES, DOMINANT; HUMANS; INFLAMMATION; LUNG; MACROPHAGES; MALE; MIDDLE AGED; NEUTROPHILS; PULMONARY ALVEOLI; PULMONARY FIBROSIS;

EID: 0022593011     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM198605223142103     Document Type: Article

References (35)

1. Crystal RG, Fulmer JD, Roberts WC, Moss ML, Line BR, Reynolds HY. Idiopathic pulmonary fibrosis: clinical, histologic, radiographic, physiologic, scintigraphic, cytologic, and biochemical aspects. Ann Intern Med 1976; 85: 769–88.
2. Crystal RG, Gadek JE, Ferrans VJ, Fulmer JD, Line BR, Hunninghake GW. Interstitial lung disease: current concepts of pathogenesis, staging, and therapy. Am J Med 1981; 70: 542–68.
3. Scadding JG. Fibrosing alveolitis. Br J Med 1964; 2: 686.
4. Crystal RG, Bitterman PB, Rennard SI, Hance AJ, Keogh BA. Interstitial lung diseases of unknown cause: disorders characterized by chronic inflammation of the lower respiratory tract. NEngl J Med 1984; 310: 154–66, 235–44.
5. Liebow AA, Carrington CB. The interstitial pneumonias. In: Simon M, Potchen EJ, Le May M, eds. Frontiers of pulmonary radiology. New York: Grune & Stratton, 1969:102–41.
6. Spencer H. Interstitial pneumonia. Annu Rev Med 1967; 18: 423–42.
7. Turner-Warwick M, Burrows B, Johnson A. Cryptogenic fibrosing alveolitis: clinical features and their influence on survival. Thorax 1980; 35: 171–80.
8. Fulmer JD, Roberts WC, von Gal ER, Crystal RG. Small airways in idiopathic pulmonary fibrosis: comparison of morphologic and pysiologic observations. J Clin Invest 1977; 60: 595–610.
9. Fulmer. Morphologic-physiologic correlates of the severity of fibrosis and degree of cellularity in idiopathic pulmonary fibrosis. J Clin Invest 1979; 63: 665–76.
10. Line BR, Fulmer JD, Reynolds HY, et al. Gallium-67 citrate scanning in the staging of idiopathic pulmonary fibrosis: correlation with physiologic and morphologic features and bronchoalveolar lavage. Am Rev Respir Dis 1978; 118: 355–65.
11. Reynolds HY, Fulmer JD, Kazmierowski JA, Roberts WC, Frank MM, Crystal RG. Analysis of cellular and protein content of broncho-alveolar lavage fluid from patients with idiopathic pulmonary fibrosis and chronic hypersensitivity pneumonitis. J Clin Invest 1977; 59: 165–75.
12. Weinberger SE, Kelman JA, Elson NA, et al. Bronchoalveolar lavage in interstitial lung disease. Ann Intern Med 1978; 89: 459–66.
13. Hunninghake GW, Gadek JE, Kawanami O, Ferrans VJ, Crystal RG. Inflammatory and immune processes in the human lung in health and disease: evaluation by bronchoalveolar lavage. Am J Pathol 1979; 97: 149—206.
14. Hunninghake GW, Gadek JE, Lawley TJ, Crystal RG. Mechanisms of neutrophil accumulation in the lungs of patients with idiopathic pulmonary fibrosis. J Clin Invest 1981; 68: 259–69.
15. Rennard SI, Hunninghake GW, Bitterman PB, Crystal RG. Production of fibronectin by the human alveolar macrophage: mechanism for the recruitment of fibroblasts to sites of tissue injury in interstitial lung diseases. Proc Natl Acad Sci USA 1981; 78: 7147–51.
16. Bitterman PB, Rennard SI, Adelberg S, Crystal RG. Role of fibronectin as a growth factor for fibroblasts. J Cell Biol 1983; 97: 1925–32.
17. Bitterman PB, Rennard SI, Hunninghake GW, Crystal RG. Human alveolar macrophage growth factor for fibroblasts: regulation and partial characterization. J Clin Invest 1982; 70: 806–22.
18. Bitterman PB, Adelberg S, Crystal RG. Mechanisms of pulmonary fibrosis: spontaneous release of the alveolar macrophage-derived growth factor in the interstitial lung disorders. J Clin Invest 1983; 72: 1801–13.
19. Sandoz E. Über zwei Fålle von “Fötaler Bronchektasie.” Beitr Path Anat 1907: 495–516.
20. Peabody JW, Peabody JW Jr, Hayes EW, Hayes EW Jr. Idiopathic pulmonary fibrosis: its occurrence in identical twin sisters. Dis Chest 1950; 18: 330–43.
21. MacMillan JM. Familial pulmonary fibrosis. Dis Chest 1951; 20: 426–36.
22. Donohue WL, Laski B, Uchida I, Munn JD. Familial fibrocystic pulmonary dysplasia and its relation to the Hamman-Rich syndrome. Pediatrics 1959; 24: 786–813.
23. Koch B. Familial fibrocystic pulmonary dysplasia: observations in one family. Can Med Assoc J 1967; 92: 801–8.
24. Bonanni PP, Frymoyer JW, Jacox RF. A family study of idiopathic pulmonary fibrosis: a possible dysproteinemic and genetically determined disease. Am J Med 1965; 39: 411–21.
25. Adelman AG, Chertkow G, Hayton RC. Familial fibrocystic pulmonary dysplasia: a detailed family study. Can Med Assoc J 1966; 95: 603–10.
26. Swaye P, Van Ordstrand HS, McCormack LJ, Wolpaw SE. Familial Hamman-Rich syndrome: report of eight cases. Dis Chest 1969; 55: 7–12.
27. Solliday NH, Williams JA, Gaensler EA, Couru RE, Carrington CB. Familial chronic interstitial pneumonia. Am Rev Respir Dis 1973; 108: 193–204.
28. Bitterman PB, Crystal RG. Is there a fibrotic gene? Chest 1980; 78: 549–50.
29. Rennard SI, Berg R, Martin GR, Foidart JM, Gehron-Robey R. Enzyme-linked immunoassay (ELISA) for connective tissue components. Anal Biochem 1980; 104: 205–14.
30. Hunninghake GW, Crystal RG. Cigarette smoking and lung destruction: accumulation of neutrophils in the lungs of cigarette smokers. Am Rev Respir Dis 1983; 128: 833–8.
31. Fels AOS, Pawlowski NA, Cramer EB, King TKC, Cohn ZA, Scott WA. Human alveolar macrophages produce leukotriene B4. Proc Natl Acad Sci USA 1982; 79: 7866–70.
32. Gauss-Müller V, Kleinman HK, Martin GR, Schiffmann E. Role of attachment factors and attractants in fibroblast chemotaxis. J Lab Clin Med 1980; 96: 1071–80.
33. Postlethwaite AE, Keski-Oja J, Balian G, Kang AH. Induction of fibroblast chemotaxis by fibronectin: location of the chemotactic region to a 140,000-molecular weight non-gelatin-binding fragment. J Exp Med 1981; 153: 494–9.
34. Gusella JF, Wexler NS, Conneally PM, et al. A polymorphic DNA marker genetically linked to Huntington's disease. Nature 1983; 306: 234–8.
35. Musk AW, Zilko TJ, Manners P, Kay PH, Cambolt MI. Genetic studies in familial fibrosing alveolitis: possible linkage with immunoglobulin allotypes (Gm). Chest 1986; 89: 206–10.